UK Govt Spent £16m on Two Million Chinese-Made

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
234
UK Govt Spent £16m on Two Million
Chinese-Made Coronavirus Tests that
Didn’t Work < >

Chinese-coronavirus-640x480.jpg

The British government reportedly spent £16 million on two million coronavirus home test kits from two separate Chinese companies, none of which work.

The New York Times claimed on Friday that a laboratory at Oxford University found that the tests, intended to be rolled out as home kits, were insufficiently accurate at detecting antibodies. The American newspaper alleged that half a million from one company are now in storage and the other 1.5 million from the second Chinese firm have also gone unused. The tests were manufactured by AllTest Biotech and Wondfo Biotech, both of which claim that their products met European Union (EU) standards.

Following complaints from the British government that the tests were useless, both Chinese companies attempted to blame British officials for misunderstanding how the tests worked, with Wanfo Biotech claiming that the test for only to be used supplementarily for patients who already knew that they had the virus.

A spokesman from the Department of Health and Social Care told the newspaper that the government had ordered the smallest batch the vendors would sell, and it would seek to recuperate taxpayers’ money for the faulty medical equipment.

It is unclear if these tests are the very same batch of millions of faulty Chinese-made tests that the British government admitted to having bought at the beginning of this month.

Professor John Newton of Public Health England (PHE) — the government’s official executive agency responsible for public health in England — had said that the Chinese tests had been validated against patients who had been severely ill. In contrast, the United Kingdom needed tests that required a range of infection levels to pick up those with the antibodies.

However, the New York Times report may point to the scale of taxpayers’ money being spent on faulty medical equipment purchased from the very country where the pandemic originated.

Sue Communist China for Coronavirus Pandemic, Says British Think Tank https://t.co/l0oC6EFqyO

— Breitbart London (@BreitbartLondon) April 6, 2020

The Daily Mail said that Downing Street did not deny the claims put out by the NYT, but a spokesman for Prime Minister Boris Johnson said he was not aware of the specific £16 million figure. The spokesman told the British newspaper: “Where tests are shown not to have any prospect of working then we will seek to recover as much of the costs as we can.”

A Department of Health and Social Care spokesman also told The Sun: “We are currently working with a number of companies on finding fast, reliable antibody tests and are in the process of evaluating their effectiveness.

“These tests could be transformational, and we are working round the clock to gain regulatory approval. It is crucial we are satisfied of their safety and accuracy before making them available.

“We have bought our current stock on the basis of minimum initial volumes, which are being clinically tested. If tests don’t work, orders will be cancelled, and costs recovered wherever possible.”

If the reports are accurate, it would fit the profile of Chinese companies taking advantage of European countries in crisis by selling them shoddy or overpriced equipment. Last month, the Netherlands had to recall 600,000 masks sent from China that were found to have faulty filters, for example.

Spain also had received thousands of coronavirus tests from Chinese company Shenzen Bioeasy Biotechnology Company Limited which proved useless. Again, the company claimed that its products were EU certified.

China’s communist regime also attempted to avoid responsibility, with the Chinese embassy in Madrid implying that the Spanish government was at fault.

A diplomatic source in Spain had warned that Chinese companies were taking advantage of the situation, with some costs increasing by tenfold and companies in China demanding payment upfront.

Farage: Huawei in UK 5G May Be Price for Accepting China’s Coronavirus Aid https://t.co/mCgrCfsoj7

— Breitbart London (@BreitbartLondon) April 7, 2020

The United Kingdom, Spain, and the Netherlands are just a handful of Western countries desperately scrambling to obtain vital personal protection equipment, medicines, ventilators, and tests from Chinese suppliers because their own domestic supply chains have been decimated by decades of globalisation.

Writing last month, Brexit Party leader Nigel Farage said that the Chinese coronavirus pandemic had exposed the West’s dependency on China in its supply chains. Italy, the epicentre of the epidemic, has been forced to accept support from Xi Jinping’s communist regime due to the EU’s failure to help its member-state.

Mr Farage wrote of the situation: “To see China now exploiting a crisis that they have caused to spread their influence further and deeper into Europe should send a chill down our spines.”

Mr Farage also warned in April that Chinese interests are lining up to take advantage of the economic disruption caused by the Chinese coronavirus crisis hoping for a “fire sale” of British businesses so they can buy up “vast swathes of our strategic and manufacturing industries”.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 11

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Community Heritage Financial Declares Q3 2026 Dividend

Updated Category News Views 4

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 5

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
Honeywell Aerospace Faces Securities Fraud Lawsuit

Updated Category News Views 8

Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 9

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 5

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 12

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 20

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 8

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
F.N.B. Q3 2026 Earnings: Solid Growth Continues

Updated Category News Views 4

F.N.B. Stays the Course with Strong Q3 2026 Ever heard the phrase “slow and steady wins the race?” That seems to be the mantra over at F.N.B. Corporation (NYSE: FNB) as they roll out their Q3 2026 earnings. Now, they aren't breaking any land speed records, but what they are doing is consistently stepping up their game, quarter by quarter, like clockwork. Drilling Down...

Continue Reading

Top 5 Most Recently Viewed Articles

Profiting from SPDR Gold MiniShares Trust: 5-Year Review

Updated Category News Views 118

Understanding the SPDR Gold MiniShares Trust Performance SPDR Gold MiniShares Trust (NYSE: GLDM) has shown impressive returns over the past five years, outperforming the market by an average of 5.19% annually. With a market cap currently estimated at $25.61 billion, this fund has attracted the attention of investors looking to diversify their portfolios with gold. Initial...

Continue Reading
Ortel Announces Major Advancements in Laser Technology

Updated Category News Views 370

Ortel's Strategic Move for Laser Fabrication Transfer Ortel, a prominent enterprise in photonics, has made headlines with the recent announcement regarding its wafer fabrication transfer for the C-Band High-Power Continuous Wave Laser Module platform. This significant shift to the Canadian Photonics Fabrication Centre (CPFC) marks a pivotal moment for the company,...

Continue Reading
GENFIT's GNS561 Aims to Revolutionize Cancer Treatment Options

Updated Category News Views 184

Unveiling the Promise of GNS561 in Combination Therapy Recent findings from GENFIT have unveiled striking early results from an ongoing clinical study involving GNS561, an innovative investigational drug. The combination of GNS561 with a MEK inhibitor (MEKi) is showing encouraging potential, especially for patients suffering from KRAS mutated cholangiocarcinoma (CCA), a...

Continue Reading
Notable Shareholding Changes for Spar Nord Fonden Announced

Updated Category News Views 81

Spar Nord Fonden's Major Shareholder Update Announcement Overview In a noteworthy step within the financial sector, Spar Nord Fonden has informed Spar Nord Bank A/S of an increase in its ownership. They've amassed a total of 23,853,707 shares, which represents 20.27% of Spar Nord Bank A/S's total share capital. This significant move not only showcases Spar Nord Fonden's...

Continue Reading
Equiduct Announces Martin Andersson as New Nordic Head

Updated Category News Views 188

Martin Andersson Joins Equiduct as Head of Nordics Equiduct is excited to introduce Martin Andersson as the new Head of Nordics. With more than 25 years in financial markets, Martin brings expertise that promises to enhance Equiduct's vision and strategy within the Nordic region. A Wealth of Experience in Financial Markets Before joining Equiduct, Martin developed a...

Continue Reading